Financials in USD. Standardized financial statements.
A compact view of how Centogene N.V. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $48.54M | $47.47M | $42.23M | $38.45M | $48.78M | $40.48M | $31.69M | $27.67M |
| Revenue Growth? | +2.2% | +12.4% | +9.8% | -21.2% | +20.5% | +27.7% | +14.5% | 0.0% |
| Cost of Revenue? | $31.29M | $27.55M | $27.67M | $35.29M | $26.00M | $19.94M | $14.94M | $12.86M |
| Gross Profit? | $17.25M | $19.92M | $14.57M | $3.17M | $22.77M | $20.54M | $16.75M | $14.81M |
| Gross Margin? | +35.5% | +42.0% | +34.5% | +8.2% | +46.7% | +50.7% | +52.9% | +53.5% |
| Operating Expenses? | $46.91M | $56.53M | $72.98M | $60.18M | $42.11M | $31.30M | $21.40M | $19.96M |
| Operating Income? | -$29.66M | -$36.77M | -$55.49M | -$53.73M | -$19.34M | -$10.61M | -$4.46M | -$5.03M |
| EBITDA? | -$19.43M | -$24.65M | -$36.65M | -$43.67M | -$12.09M | -$5.40M | -$1.29M | -$2.94M |
| Income Before Tax | -$35.24M | -$38.60M | -$57.42M | -$59.81M | -$20.70M | -$11.65M | -$5.46M | -$5.77M |
| Income Tax Expense | $287,000 | $107,000 | -$70,000 | $224,000 | $158,000 | -$310,000 | $14,000 | -$408,000 |
| Net Income? | -$35.53M | -$31.84M | -$46.25M | -$21.38M | -$20.86M | -$11.34M | -$5.48M | -$5.36M |
| EPS? | $-1.27 | $-1.11 | $-2.09 | $-1.02 | $-1.27 | $-0.57 | $-0.28 | $-0.27 |
| Diluted EPS? | $-1.26 | $-1.11 | $-2.09 | $-1.02 | $-1.27 | $-0.57 | $-0.28 | $-0.27 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality